← @andybiotech

$AMGN

BEARISH2022-09-12
By horizon✓ hit-0.9%
1d
5d
-3.8%
21d
-0.9%
Original post
Andy Biotech · 2022-09-12

#ESMO22 $AMGN Lumakras very underwhelming Codebreak-200 data on top of an already slow launch How to justify $18K/mo price w/ ~1mo mPFS benefit and detrimental overall survival? Double whammy day w/ $BMY Sotyktu clean label re. Otezla. Silver lining: more need for SMID bio M&A? https://t.co/yUJzraVg36

View on X ↗